Mass spectrometry (MS) has emerged as a pivotal tool in the characterization of polymers, providing unparalleled insights into molecular weights, chemical compositions, and sequence distributions.
Nitrotyrosine, a nitrated derivative of the amino acid tyrosine, serves as an established biomarker for nitrosative stress and related pathophysiological conditions. Its formation occurs through the ...
Researchers developed a multi-channel mass spectrometry system that processes ions in parallel, enhancing signal detection, ...
A new mass spectrometry technique sorts molecules to capture those of lower abundance. For scientists, a molecule’s weight can help determine its makeup. For measures like this, researchers turn to a ...
A new prototype could supercharge mass spectrometry by analyzing thousands of molecules at once instead of one by one. The ...
insights from industryJeff ZondermanSenior Vice PresidentBruker Applied Mass Spectrometry In this interview, AZoM speaks to Jeff Zonderman from Bruker Applied Mass Spectrometry about the future of ...
To identify specific chemicals or molecules in the life sciences and medical research, scientists often use mass spectrometry (MS), usually paired with liquid chromatography (LC). These technologies ...
In this webinar, Dr. Johann Stojko, experienced biophysicist at Novalix, will present integrated workflows that combine ...
For biologists, seeing is believing. But sometimes biologists have a hard time seeing. One particularly vexing challenge is seeing all the molecules in an intact tissue sample, down to the level of ...
Morning Overview on MSN
Prototype mass spectrometer analyzes up to 1B molecules at once
A reengineered mass spectrometer prototype can now analyze up to a billion molecules simultaneously, a leap from conventional ...
Morning Overview on MSN
Rockefeller prototype mass spectrometer analyzes 1B molecules at once
Scientists at The Rockefeller University have built a prototype mass spectrometer that can process over a billion molecules ...
Researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry (MS) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果